Trial Update November 12, 2026

Trial on Water Intake, Vasopressin and Muscle Function Begins Recruiting

A clinical trial titled "The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older Adults" was listed as recruiting on November 12, 2026. The study, registered as NCT07892742, does not have a specified phase. It is designed to examine endocrine regulation, which includes vasopressin, alongside muscle function and physical performance in older adults identified as low water drinkers. The trial status is currently recruiting, meaning participant enrollment is underway as of the listed date. No results or outcome data have been reported at this stage. The trial record does not provide efficacy or safety findings related to vasopressin or any other measured outcome. Vasopressin remains an approved compound, and this trial update reflects only its current recruitment status within this specific study context. Readers interested in background information on vasopressin can consult the compound overview for additional context.

See the full vasopressin overview

Source: https://clinicaltrials.gov/study/NCT07892742